Literature DB >> 17479527

Treating delusional disorder: a comparison of cognitive-behavioural therapy and attention placebo control.

Kieron O'Connor1, Emmanuel Stip, Marie-Claude Pélissier, Frederick Aardema, Stéphane Guay, Gilles Gaudette, Ian Van Haaster, Sophie Robillard, Sébastien Grenier, Yves Careau, Pascale Doucet, Vicky Leblanc.   

Abstract

OBJECTIVE: Cognitive-behavioural therapy (CBT) has proved effective in treating delusions, both in schizophrenia and delusional disorder (DD). Clinical trials of DD have mostly compared CBT with either treatment as usual, no treatment, or a wait-list control. This current study aimed to assess patients with DD who received CBT, compared with an attention placebo control (APC) group.
METHOD: Twenty-four individuals with DD were randomly allocated into either CBT or APC groups for a 24-week treatment period. Patients were diagnosed on the basis of structured clinical interviews for mental disorders and the Maudsley Assessment of Delusion Schedule (MADS).
RESULTS: Completers in both groups (n = 11 for CBT; n = 6 for APC) showed clinical improvement on the MADS dimensions of Strength of Conviction, Insight, Preoccupation, Systematization, Affect Relating to Belief, Belief Maintenance Factors, and Idiosyncrasy of Belief.
CONCLUSION: When compared with APC, CBT produced more impact on the MADS dimensions for Affect Relating to Belief, Strength of Conviction, and Positive Actions on Beliefs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479527     DOI: 10.1177/070674370705200310

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  16 in total

1.  Heavy resistance training and peri-exercise ingestion of a multi-ingredient ergogenic nutritional supplement in males: effects on body composition, muscle performance and markers of muscle protein synthesis.

Authors:  Mike Spillane; Neil Schwarz; Darryn S Willoughby
Journal:  J Sports Sci Med       Date:  2014-12-01       Impact factor: 2.988

2.  The 10th Anniversary of the Eli Lilly Chair of Schizophrenia from the University of Montreal.

Authors:  Emmanuel Stip; Stéphane Potvin
Journal:  Can J Psychiatry       Date:  2015-03       Impact factor: 4.356

3.  Skeletal Muscle Estrogen Receptor Activation in Response to Eccentric Exercise Up-Regulates Myogenic-Related Gene Expression Independent of Differing Serum Estradiol Levels Occurring during the Human Menstrual Cycle.

Authors:  Mackenzie Haines; Sarah K McKinley-Barnard; Thomas L Andre; Josh J Gann; Paul S Hwang; Darryn S Willoughby
Journal:  J Sports Sci Med       Date:  2018-03-01       Impact factor: 2.988

4.  Eight Weeks of Phosphatidic Acid Supplementation in Conjunction with Resistance Training Does Not Differentially Affect Body Composition and Muscle Strength in Resistance-Trained Men.

Authors:  Thomas L Andre; Joshua J Gann; Sarah K McKinley-Barnard; Joon J Song; Darryn S Willoughby
Journal:  J Sports Sci Med       Date:  2016-08-05       Impact factor: 2.988

Review 5.  Differences between delusional disorder and schizophrenia: A mini narrative review.

Authors:  Alexandre González-Rodríguez; Mary V Seeman
Journal:  World J Psychiatry       Date:  2022-05-19

6.  Daily Overfeeding from Protein and/or Carbohydrate Supplementation for Eight Weeks in Conjunction with Resistance Training Does not Improve Body Composition and Muscle Strength or Increase Markers Indicative of Muscle Protein Synthesis and Myogenesis in Resistance-Trained Males.

Authors:  Mike Spillane; Darryn S Willoughby
Journal:  J Sports Sci Med       Date:  2016-02-23       Impact factor: 2.988

7.  Heavy Resistance Training and Supplementation With the Alleged Testosterone Booster Nmda has No Effect on Body Composition, Muscle Performance, and Serum Hormones Associated With the Hypothalamo-Pituitary-Gonadal Axis in Resistance-Trained Males.

Authors:  Darryn S Willoughby; Mike Spillane; Neil Schwarz
Journal:  J Sports Sci Med       Date:  2014-01-20       Impact factor: 2.988

8.  Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia.

Authors:  Christopher Jones; David Hacker; Jun Xia; Alan Meaden; Claire B Irving; Sai Zhao; Jue Chen; Chunhu Shi
Journal:  Cochrane Database Syst Rev       Date:  2018-12-20

9.  Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia.

Authors:  Christopher Jones; David Hacker; Alan Meaden; Irene Cormac; Claire B Irving; Jun Xia; Sai Zhao; Chunhu Shi; Jue Chen
Journal:  Cochrane Database Syst Rev       Date:  2018-11-15

10.  Effects of eight weeks of an alleged aromatase inhibiting nutritional supplement 6-OXO (androst-4-ene-3,6,17-trione) on serum hormone profiles and clinical safety markers in resistance-trained, eugonadal males.

Authors:  Dan Rohle; Colin Wilborn; Lem Taylor; Chris Mulligan; Richard Kreider; Darryn Willoughby
Journal:  J Int Soc Sports Nutr       Date:  2007-10-19       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.